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ABSTRACT 27 
Introduction: Physical activity (PA), including structured exercise is an essential component 28 
in the management of cystic fibrosis (CF). The use of telehealth such as video-calling may be 29 
a useful method for the delivery of exercise and PA interventions, though the feasibility of this 30 
remains unknown.   31 
Methods: Nine patients with CF (three female, six male, 30.9 ± 8.7 years) volunteered to 32 
participate. Participants completed an 8-week exercise training intervention conducted via 33 
Skype, using personalised exercises, with all sessions supervised by an exercise therapist. 34 
Feasibility was assessed by demand, implementation, practicality and acceptability. Changes 35 
in anthropometric, pulmonary, PA and quality of life (QoL) variables were also assessed.  36 
Results: Two male participants withdrew from the study, citing lack of available time. 37 
Remaining participants found use of Skype useful, with a mean satisfaction rating of 9/10, and 38 
three participants requesting to continue the sessions beyond the duration of the study. Mean 39 
compliance with sessions was 68%, with mean duration of sessions being 20 minutes. A total 40 
of 25% of calls suffered from technical issues such as video or audio lags. Anthropometric, 41 
pulmonary, PA and QoL variables remained unchanged over the course of the study period.  42 
Discussion: The use of Skype to deliver an exercise intervention to patients with CF was found 43 
to be technologically feasible, and acceptable among participants. Findings have implications 44 
for clinical practice and could allow care teams to engage patients remotely in exercise. Further 45 
research is required to assess the efficacy of this modality on increasing PA and associated 46 
health outcomes.  47 
 48 
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 50 
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1. INTRODUCTION 52 
It is well established that physical activity (PA) – which includes structured exercise – is 53 
beneficial for patients with cystic fibrosis (CF), with increased PA being associated with higher 54 
levels of aerobic fitness (1) and slower rates of decline in lung function (2). Patients are 55 
therefore recommended to remain physically active and exercise frequently, with global PA 56 
guidelines of 150 minutes of moderate-vigorous PA (MVPA) per week for adults, and 60 57 
minutes of MVPA daily for children also being appropriate for patients with CF (3). However, 58 
adherence rates to treatment (including exercise) are variable (4) and it has subsequently been 59 
suggested that supervision of exercise, and its subsequent incorporation into the home 60 
environment, could improve adherence (5).  61 
 62 
Telehealth technologies, including video-calling software such as Skype, self-care and 63 
monitoring applications can potentially change how patients with CF engage with healthcare 64 
services and reduce burden of care (6), improve monitoring (7) and potentially reduce costs 65 
associated with healthcare delivery (8). Furthermore, factors that may negatively affect health 66 
outcomes, such as risk of cross-infection (9) could potentially be overcome by the use of 67 
telehealth systems.  68 
 69 
Previous research suggests that patients with CF are willing to adopt and utilise such telehealth 70 
technology (10), and that use of an online platform to engage patients in PA is feasible and 71 
acceptable (11). Furthermore it feasible for both patients and practitioners to assess exercise 72 
capacity remotely (12). Whilst this data provides evidence for the feasibility of remote 73 
monitoring of PA and exercise capacity, the feasibility of delivering a supervised exercise 74 
intervention is yet to be explored.  75 
 76 
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Supervised exercise training is effective in improving lung function and exercise capacity in 77 
patients with CF (13). However, the gym- and hospital-based nature of these interventions can 78 
burden patients with increased travel and parking costs, gym membership fees and exposure to 79 
cross-infection risks through regular hospital visits. Home-based interventions may also 80 
positively affect lung function in patients with CF (14) and therefore warrant further 81 
investigation and implementation.  82 
 83 
It is currently unclear whether implementing supervised, online, exercise sessions using 84 
telehealth is feasible or acceptable among patients with CF. Therefore, this study sought to 85 
assess the feasibility of utilising an online video-calling platform to engage patients with CF in 86 
a personalised exercise regimen. This was primarily assessed by demand, implementation, 87 
practicality and acceptability of the intervention; and secondly by identifying issues associated 88 
with the online delivery of the intervention. 89 
 90 
2. METHODS 91 
2.1. Study Population  92 
Nine patients (three females, six males; 30.9 ± 8.7 years, range = 15.5 – 42.1) with CF were 93 
recruited from outpatient clinics at the Royal Devon and Exeter NHS Foundation Trust 94 
Hospital. Participants were eligible to participate if they were ≥14 years of age and clinically 95 
stable at the time of recruitment. To minimise impact upon usual clinical service, recruitment 96 
was staggered over seven months (March – October 2017). Participant characteristics are listed 97 
in Table 1.  98 
 99 
2.2. Ethics Approval 100 
All participants provided written informed consent (or assent, with parental consent where 101 
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applicable) upon enrolment. Ethics approval for this study was provided by an NHS Regional 102 
Ethics Committee (Cornwall & Plymouth REC) and the Health Research Authority 103 
(16/SW/0175).  104 
 105 
2.3. Timeline 106 
The period of investigation lasted 12-weeks, with a video-calling intervention occupying the 107 
first 8-weeks, and a further 4-week observation period. Figure 1 details when measurements 108 
associated with the study were taken, and when the intervention period occurred.   109 
 110 
2.4. Intervention 111 
All participants undertook 8-weeks of video-calls (Skype™, Microsoft, Luxembourg), 112 
supervised by the same exercise therapist, receiving up to 3 supervised exercise sessions per 113 
week.  114 
 115 
Skype was chosen as it was freely available for all participants and provided secure end-to-end 116 
encryption (therefore falling in line with hospital requirements for computer software). All 117 
exercise sessions were booked as per any regular outpatient appointment, being pre-arranged 118 
between participant and therapist at convenient times for both parties, provided these were a) 119 
within working hours for the therapist (0800 – 1700) for security and safety reasons, and b) the 120 
gymnasium facility was available. All sessions were placed upon the hospital ‘Patient 121 
Administration System [PAS]’ as per usual clinical appointments. For the exercise therapist, 122 
sessions were delivered on a laptop connected to the hospital Wi-Fi network, in a small 123 
gymnasium on an outpatient therapy ward that could be booked by any staff member within 124 
the ‘Therapy Services’ division of the hospital trust.   125 
 126 
Page 6 of 26 
 
Exercise sessions were intended to be 30 minutes in duration, as per national PA guidelines 127 
(3). All sessions were undertaken in participants own home, on a one-to-one basis with the 128 
exercise therapist. Content of each session was personalised to each participant for the purposes 129 
of this study, dependent on equipment available in participants homes. Some participants 130 
utilised equipment such as bikes and treadmills, with others using free-weights, resistance-131 
bands or body-weight exercises. The frequency, intensity and timings of exercises throughout 132 
the sessions were aligned with participants own preferences and capabilities, although a broad 133 
‘interval’ approach to exercises was adopted as this has shown to be beneficial to individual 134 
with CF (15), and provides regular breaks for individuals to recover.  135 
 136 
2.5. Anthropometric and Pulmonary Measures 137 
Stature was measured to the nearest 0.1 cm (Holtain stadiometer, Crymych, UK) and body 138 
mass to the nearest 0.1 kg (Seca, Birmingham, UK), with body-mass index (BMI) subsequently 139 
calculated. Body-fat percentage (and subsequent fat-free mass) was identified using bio-140 
electrical impedance (Quadscan 4000; Bodystat, Douglas, Isle of Man). Estimates of arterial 141 
blood oxygenation (SaO2) were recorded using a pulse-oximeter (Nellcor; Medtronic, 142 
Minneapolis, USA). Measures of forced expiratory volume in one-second (FEV1), forced vital 143 
capacity (FVC) were obtained using a spirometer (Vitalograph Alpha; Vitalograph, 144 
Buckingham, UK and COPD-6, Vitalograph, Buckingham, UK) and normalised to percentage 145 
of their predicted value (16).  146 
 147 
2.6. Physical Activity Measurement 148 
PA was recorded for 7 days at each time point (baseline, 4, 8, 12 weeks), using an accelerometer 149 
(GENEActiv; ActivInsights, Kimbolton, UK) worn on the participants non-dominant wrist. 150 
Participants were asked to wear it during all waking hours and complete an activity log to 151 
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qualitatively describe activity undertaken. Data was analysed in 60-second epochs, using pre-152 
validated cut points (17, 18) and data from at least two days with ten hours each (19) was 153 
included for analyses to determine time spent (in minutes, and as percentage of wear time) in 154 
sedentary, light, moderate and vigorous PA domains. 155 
 156 
2.7. Quality of Life 157 
QoL was assessed using the CF Questionnaire-Revised (CFQ-R) (20), providing an indication 158 
of QoL across a range of domains. A value of 100 represents an optimal score.  159 
 160 
2.8. Assessment of Feasibility 161 
Feasibility and satisfaction of using video-calling was assessed at 8-weeks using a feedback 162 
questionnaire developed in conjunction with the local Research and Development team for the 163 
hospital trust (Supplement 1). To determine feasibility, guidelines set by Bowen et al. (21) 164 
were utilised. Primary areas of evaluation for this particular intervention were demand, 165 
implementation (study and session completion), practicality (technical issues) and acceptability 166 
(participant feedback). Furthermore, analysis of anthropometric, pulmonary, PA and quality of 167 
life (QoL) variables (described below) was purely descriptive in nature, with means and 168 
standard deviations reported for each variable, but no formal statistical procedures taking place 169 
(due to the feasibility nature of the study and insufficient statistical power).  170 
 171 
3. RESULTS 172 
3.1. Demand 173 
Of the nine participants who undertook exercise sessions, two failed to complete the study. 174 
Both participants were male (42 years, BMI 27.8 kg.m-2, FEV1 59%Predicted and 26 years, BMI 175 
24.2 kg.m-2, FEV1 23%Predicted) and withdrew due to time constraints, one prior to their first 176 
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scheduled exercise session, and one after their first week of the intervention. In contrast, three 177 
participants requested to continue delivery of exercise sessions beyond the scheduled study. 178 
These participants commenced additional sessions as part of routine clinical care following the 179 
one-month follow up observations. No adverse events related to exercise during the study were 180 
reported by either participants, nor the exercise therapist delivering the intervention.  181 
 182 
3.2. Acceptability of Intervention 183 
Of the participants to undertake exercise sessions, compliance was variable. A total of 88 184 
sessions were booked with participants, with 59 being attended by participants. Individual 185 
compliance varied from 3/9 sessions (33%) to 10/10 sessions (100%) (mean = 68%). Of the 29 186 
sessions not attended, reasons included: illness (n = 13 [45%]; including 9 missed by one 187 
participant’s exacerbation leading to admission); work-related commitments (n = 8; 28%), 188 
school-related commitments (n = 2; 7%), unexplained non-attendance (n = 2; 7%), transport 189 
(to home) issues (n = 2; 7%), participant cancellation (n = 1; 3%) and vacation (n = 1; 3%).  190 
 191 
Of the training sessions completed, duration ranged from 12 – 29 minutes (mean = 20 minutes). 192 
Sessions fell short of the desired 30 minutes in duration, due to both clinical restraints (e.g. 193 
gymnasium bookings, staffing requirements) and participant preferences for shorter sessions. 194 
Total contact time between therapist and participants for the 59 attended sessions equalled 18 195 
hours and 21 minutes.  196 
 197 
3.3. Implementation 198 
Of the seven participants to complete the post-intervention feedback questionnaire, four had 199 
used video-calling software previously: Skype (n = 2; 29%); Business Skype (n = 1; 14%); 200 
iPhone Facetime (n = 1; 14%); with three participants (43%) using it for the first time due to 201 
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this study. Six of seven participants (86%) reported it was ‘easy’ to set up Skype, with one 202 
(14%) reporting set up as ‘OK’.  203 
 204 
Participants used differing devices to connect via Skype including laptop (n = 4; 57%), 205 
smartphone (n = 2; 29%) and tablet (n = 1; 14%). Connections were made over Wi-Fi (n = 4; 206 
57%), broadband (n = 2; 29%) and fibre broadband (n = 1; 14%), with four participants (57%) 207 
reporting connection issues. These issues were experienced on differing devices and types of 208 
connection (tablet/Wi-Fi, n = 1 [14%]; laptop/broadband, n = 1 [14%]; smartphone/Wi-Fi, n = 209 
1 [14%]; laptop/fibre broadband, n = 1 [14%]). Sound quality was rated ‘good’ by 3/7 (43%) 210 
participants and ‘OK’ by 4/7 (57%) participants. Video quality was rated ‘good’ by 4/7 (57%) 211 
participants and ‘OK’ by 3/7 (43%) participants.  212 
 213 
A total of 22 technical issues were reported by staff administering the intervention, for 15/59 214 
(25%) sessions. As a proportion of the number of issues, these included connection issues (n = 215 
8; 36%); delays/lags (n = 7; 32%); as well as visual (n = 4; 18%) and sound (n = 3; 14%) 216 
problems. Technical issues resulted in three video-calls (5% of total) being cancelled.    217 
 218 
3.4. Participant Feedback 219 
Participants found using Skype for exercise useful, with ratings ranging from 7/10 – 10/10 220 
(mean = 9/10). Overall satisfaction ratings, with regards to taking part in this research study, 221 
included: ‘excellent’ (n = 2; 29%), ‘very good’ (n = 3; 43%) and ‘good’ (n = 2; 29%). All 222 
participants (7/7; 100%) stated they would be happy to take part in future research studies.  223 
 224 
Four participants provided qualitative feedback via the intervention feedback questionnaire. 225 
These comments covered different topics, including their support for, and enjoyment of, the 226 
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exercise intervention: 227 
 228 
[exercise at home] …saved me a lot of hassle, not having to travel up to the hospital for 229 
exercise (Participant 1) 230 
 231 
Really enjoyable & set me up for the day (Participant 4) 232 
 233 
I found the Skype session useful (Participant 7) 234 
 235 
Participants also commented on the use of Skype as the modality of delivering the intervention, 236 
with both positive and negative comments: 237 
 238 
Connection was sometimes poor and a slight delay - was sometimes difficult hearing my 239 
physio (Participant 1) 240 
 241 
Very easy to setup and use. The connection was very good at all times (Participant 7) 242 
 243 
Comments also highlighted how the disease interfered with the delivery of the intervention: 244 
 245 
Unfortunately, I was poorly for a couple of weeks so I didn't get to exercise as much as I 246 
would have liked to (Participant 1) 247 
 248 
Finally, participants also provided suggestions for further enhancements of the study design, 249 
with specific mention of timeline of events: 250 
 251 
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Would be good to have a tailored timetable at the start detailing when each part is happening 252 
e.g. Week 1: Exercise session x2; Week 2: wear exercise watch; Week 3: Review in hospital 253 
etc. (Participant 9) 254 
 255 
3.5. Participant Outcomes  256 
Participant characteristics are listed in Table 1, with subsequent changes in body size and lung 257 
function, PA and QoL included in Tables 1, 2 and 3 respectively. The study was not powered 258 
to detect changes in these outcomes and no changes were seen across all variables during the 259 
course of the study.  260 
 261 
The majority of data was collected at each visit without issue. However, of the seven 262 
participants providing follow up data, one did not undertake body composition at 8-weeks, and 263 
three SaO2 measures (one at 8-weeks, 2 at 12-weeks) were missed; all due to non-availability 264 
of equipment. Furthermore, for PA data, of the seven participants providing follow up data, 265 
seven (of 21; 33%) PA measures across the three time points (4, 8, 12 weeks) were missed. 266 
These seven missed measurements were due to one participant not wearing the accelerometer 267 
(i.e. non-compliance, n = 3; 43%), and the remaining four due to equipment error (n = 2; 29%), 268 
inpatient admission (n = 1; 14%) and loss within the postal service when returning 269 
accelerometer to study team (n = 1; 14%).    270 
 271 
 272 
4. DISCUSSION 273 
The purpose of this study was to assess the feasibility and acceptability of using video-calling 274 
technology to implement exercise programmes to engage patients with CF in exercise training. 275 
Results suggest this modality may be feasible in practice, as it was accepted by participants 276 
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and could therefore potentially be used in clinical practice to deliver exercise interventions. 277 
Many different aspects of feasibility can be assessed to evaluate new interventions, and this 278 
study focused on the demand, implementation, practicality and acceptability (21).    279 
 280 
4.1. Demand and Implementation 281 
For assessment of demand and implementation, outcomes of interest include the actual use of 282 
the programme and the degree of execution – characterised by the number of participants to 283 
complete the study and number of sessions completed. 284 
 285 
As with any exercise intervention, a loss of study participants is to be expected, and the 286 
withdrawal of two participants (22%) in the present study is comparable to previous training 287 
interventions in people with CF, both in terms of percentage of participants (4/18; 22% (22)) 288 
and absolute numbers (13). Therefore, given the self-reported reasons of ‘time commitments’ 289 
from participants as reasons for withdrawal, and comparable attrition rates to other studies, it 290 
can be concluded that use of Skype itself is not a contributory factor in withdrawing from this 291 
intervention – a reason for withdrawal that has been previously reported in people with chronic 292 
obstructive pulmonary disease (COPD) (23).  293 
 294 
In addition to withdrawals, 32% of appointments were missed by remaining participants for 295 
various reasons, a lower rate than that seen when using Skype to deliver exercise for chronic 296 
knee pain (24). These reasons were related to lifestyle and environmental factors that could 297 
feasibly interfere with any intervention (e.g. work commitments) and were not related to the 298 
use of Skype or the internet itself. This provides further evidence that the use of a Skype is a 299 
feasible platform for use when remotely delivering an exercise intervention.  300 
 301 
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4.2. Practicality 302 
In order to assess practicality, the ability of participants to carry out the intervention must be 303 
considered. Within this study, there were multiple technical issues associated with using Skype, 304 
such as connection issues and audio/visual problems. However, these issues were not mutually 305 
exclusive and multiple issues could (and did) occur per video-contact session, thus reducing 306 
the total number of affected sessions. The 25% of sessions that were affected is a lower rate to 307 
that previously reported for an online Yoga intervention for people with COPD and heart 308 
failure (25), although the issues are similar (e.g. visual lags). 309 
 310 
Individual participants used varying platforms, and connection modalities, to operate Skype 311 
and yet all participants reported at least one technical issue. Therefore, no single connection 312 
mode or user platform can be associated with technical issues. Furthermore, as only 5% of calls 313 
were cancelled as a result of technical issues, this suggests that use of Skype as a delivery 314 
modality for exercise sessions is practically feasible. This is supported by previous use of 315 
telemedicine in CF in the United Kingdom (UK), whereby connection problems have delayed 316 
delivery of the intervention, but do not appear to have negatively affected the acceptability of 317 
remote monitoring (26). Given the increased government investment in internet infrastructure 318 
in the UK (27), it is likely such technical issues associated with video-calling will reduce in the 319 
future, further increasing the feasibility of this intervention modality.  320 
 321 
In addition to patients, interventions must also be practically feasible for clinical staff. This 322 
current intervention required a total contact time of 18 hours and 21 minutes from the exercise 323 
therapist, although this does not include clinical time associated with setting up appointments 324 
or preparing programmes for delivery. However, the online nature of sessions does mean that 325 
staff can contact patients immediately one after another (as done multiple times in the present 326 
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study), reducing the time normally required between meeting patients in the same facility due 327 
to cross-infection risks. This can therefore be viewed as an efficient use of clinical time and 328 
increases the practical feasibility of using Skype as a modality for exercise delivery.   329 
 330 
4.3. Acceptability 331 
Whilst the use of Skype does not appear to be a barrier to participation in an exercise training 332 
programme, participant support and enjoyment is fundamentally required for an intervention 333 
to be deemed acceptable. Without this participant support, any prospective development of an 334 
intervention is unlikely to succeed in the long-term.  335 
 336 
Participant feedback was largely positive in this study, with all participants who completed this 337 
study being satisfied with the study and reporting Skype as a useful platform. Furthermore, 338 
given that three participants requested to continue training sessions via Skype following the 339 
intervention, this suggests acceptability of this modality. Qualitative comments were mixed; 340 
although negative comments were related to technical issues associated with connection (which 341 
could be overcome with advancements/upgrades in software/internet speeds), as opposed to 342 
the use of an online platform and the burden of the disease itself. Positive responses to the 343 
intervention are in agreement with previous studies to utilise Skype in CF (28), osteoarthritis 344 
(29) and breast cancer (30).  345 
 346 
4.4. Anthropometrics, Pulmonary Function, PA and QoL 347 
As this study was not powered or designed to identify changes in function over time, analysis 348 
of data is limited to descriptive statistics only. However, the majority of measures were 349 
collected without issue, with the technical issues and loss within the postal system having been 350 
experienced by other studies previously (31). Furthermore, the purpose of the study was to 351 
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remotely supervise exercise, not to remotely monitor exercise responses and as such, the loss 352 
of data impacts only upon our understanding of habitual PA and does not impact upon clinical 353 
decisions that may be made on account of monitoring, as incorporated into other prospective 354 
monitoring interventions (32).  355 
 356 
When examining the data obtained from the study, mean values for all anthropometric, 357 
pulmonary, PA and QoL factors appear to have remained stable, suggesting maintenance of 358 
function when engaging in an online exercise regimen over a 12-week period. The wide 359 
standard deviation associated with each variable is likely due to a) the range of disease severity 360 
within the recruited group (as shown by baseline FEV1 ranging from 23 – 121% predicted [data 361 
not reported]), and b) admissions to hospital due to pulmonary exacerbations experienced by 362 
participants. Regardless, the lack of an overall decline in function aligns with previous studies 363 
in other clinical groups that have utilised Skype to remotely deliver exercise interventions, such 364 
as COPD (23), breast cancer (30) and chronic knee pain (24), all of which have found positive 365 
outcomes associated with online-delivered exercise.  366 
 367 
As patients with CF are recommended to undertake PA as part of disease management (3), the 368 
challenge for clinical staff is how to implement this on a personalised level, and ensure 369 
compliance. Whilst the mean duration of exercise sessions in this study was 20 minutes, below 370 
the 30 minutes of recommended daily PA (3), it has been shown that accumulation of bouts of 371 
as little as 10 minutes of MVPA could yield long-term benefits in CF (33). Therefore, use of 372 
telehealth could prove to be an integral component of future care and possibly reduce the time 373 
required on behalf of clinical teams to engage patients in exercise and PA.  374 
 375 
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The findings of the present study have implications for clinical practice, by identifying issues 376 
associated with a platform that has the potential to overcome geographical barriers and reduce 377 
cross-infection risks.  378 
 379 
4.5. Study Limitations 380 
The small samples size (due to the feasibility driven approach of this investigation) will limit 381 
the utility of findings to further groups of individuals with CF, although the findings can be 382 
used to statistically power future studies. Furthermore, the variances in the types of exercise 383 
undertaken by each participant has the potential to bias  results. Whilst a uniform training 384 
regimen would alleviate such bias, it would remove the personalised approach to each training 385 
regimen that can improve acceptance and adherence. This therefore, provides a challenge for 386 
future researchers to accommodate this trade-off between uniform and personalised approaches 387 
to exercise prescription.  388 
 389 
In conclusion, this feasibility study demonstrated that use of Skype as a telehealth platform can 390 
be successfully used to engage patients with CF in a personalised exercise regimen, and that 391 
the participants in this study responded positively to this approach. Future research is warranted 392 
to identify whether the utility of this delivery modality can effectively improve health and 393 
physical function in CF.  394 
 395 
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Table 1. Changes in anthropometric and pulmonary variables over the course of the study 498 
period.  499 
 Baseline 
(0 weeks) 
Intervention End  
(8 weeks) 
Follow Up  
(12 weeks) 
 n = 7 n = 7 n = 7 
Age (years) 30.0 (8.6) 30.2 (8.6) 30.3 (8.6) 
Height (m) 1.64 (0.09) 1.64 (0.09) 1.64 (0.09) 
Weight (kg) 61.9 (14.8) 62.2 (14.2) 62.8 (14.7) 
BMI (kg.m-2) 22.8 (3.7) 23.0 (3.6) 23.1 (3.6) 
Fat Mass (kg) 13.2 (6.3) 14.0 (6.5) 13.4 (6.7) 
Fat Mass (%) 20.8 (9.2) 21.1 (8.0) 21.1 (9.7) 
Fat Free Mass (kg) 48.7 (11.4) 50.8 (11.0) 49.4 (12.5) 
Fat Free Mass (%) 79.2 (9.2) 78.9 (8.0) 78.9 (9.7) 
Resting SaO2 (%) 97 (1) 97 (2) 98 (1) 
FEV1 (L) 2.53 (1.47) 2.51 (1.55) 2.54 (1.43) 
FEV1 (%Predicted) 74 (31) 73 (34) 73 (32) 
FVC (L)a 3.65 (1.68) 3.61 (1.71) 3.58 (1.49) 
FVC (%Predicted)
a 93 (25) 91 (27) 90 (22) 
Homozygous ∆F508 3 
Heterozygous ∆F508 4 
Other Alleles E1371X, Q220X, 2789+5G>A, D1152H 
All values reported as mean (SD). BMI, body mass index; FEV1, forced expiratory volume in 500 
1 second; FVC, forced vital capacity. Data presented for n = 7 to demonstrate the seven 501 
participants who completed the study. a: FVC only available for 6/7 participants due to positive 502 
screen of non-tuberculosis mycobacterium in one participant, whereby subsequent use of 503 
personal spirometer only provides FEV6, not FVC. 504 
 505 
 506 
 507 
 508 
 509 
 510 
 511 
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Table 2. Changes in physical activity over the course of the study period.   512 
 Baseline 
(0 weeks) 
Mid-Intervention 
(4 weeks) 
Intervention End  
(8 weeks) 
Follow Up 
(12 weeks) 
Activity Domain n = 6a n = 4b n = 6c n = 4d 
Sedentary (mins.day-1) 528 (86) 565 (61) 470 (66) 513 (151) 
Sedentary (%) 65 (8) 67 (13) 65 (12) 63 (20) 
Light (mins.day-1) 96 (20) 85 (6) 86 (40) 98 (33) 
Light (%) 12 (3) 10 (1) 14 (9) 13 (4) 
Moderate (mins.day-1) 180 (72) 201 (129) 193 (104) 196 (148) 
Moderate (%) 22 (7) 23 (13) 24 (10) 24 (16) 
Vigorous (mins.day-1) 5 (5) 6 (8) 4 (4) 2 (3) 
Vigorous (%) 1 (1) 1 (1) 1 (1)  0 (0) 
All valued are presented as means (SD). a: Baseline values for six participants, accounting for 513 
all individuals to complete study (n = 7), and loss of data due to non-wear of accelerometer (n 514 
= 1). b: 4-weeks only includes four participants due to withdrawal (n = 2), non-wear of 515 
accelerometer (n = 1), inpatient admission unrelated to interventions (n = 1), and loss of 516 
accelerometer within postal system (n = 1). c: 8-weeks only includes six participants due to 517 
withdrawal (n = 2) and non-wear of accelerometer (n = 1). d: 12-weeks only includes four 518 
participants due to withdrawal (n = 2), equipment error (n = 2), and non-wear of accelerometer 519 
(n = 1).   520 
 521 
 522 
 523 
 524 
 525 
 526 
 527 
 528 
 529 
 530 
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Table 3. Changes in quality of life (QoL) over the course of the study period.  531 
 Baseline 
(0 weeks) 
Intervention End  
(8 weeks) 
Follow Up  
(12 weeks) 
QoL Dimension n = 6a n = 6b n = 7c 
Physical 72 (34) 58 (37) 72 (33) 
Vitality 56 (25) 51 (21) 56 (24) 
Emotion 71 (27) 71 (18) 79 (18) 
Eating 80 (25) 83 (18) 88 (17) 
Treatment Burden 56 (36) 37 (24) 49 (33) 
Health Perception 70 (24) 37 (38) 52 (34) 
Social 74 (16) 62 (19) 62 (29) 
Body Image 69 (29) 69 (28) 73 (27) 
Role 75 (27) 65 (38) 77 (28) 
Weight 67 (42) 67 (30) 71 (36) 
Respiratory 52 (33) 56 (23) 64 (27) 
Digestive 85 (22) 91 (11) 87 (20) 
All valued are presented as means (SD). a: Baseline values for six participants, accounting for 532 
all individuals to complete study (n = 7), but failure of one participant to complete baseline 533 
QoL (n = 1). b: 8-weeks only includes six participants due to withdrawal from study (n = 2) 534 
and loss of QoL questionnaire within postal system (n = 1). c: 12-weeks only includes seven 535 
participants due to withdrawal from study (n = 2).   536 
 537 
 538 
 539 
 540 
 541 
 542 
 543 
 544 
 545 
 546 
 547 
 548 
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Figure 1. Schematic representation of assessment and intervention time points.  549 
 550 
 551 
 552 
 553 
 554 
 555 
 556 
 557 
 558 
 559 
 560 
 561 
SUPPLEMENTARY FILES  562 
Supplement 1. Study feedback questionnaire administered to participants, following 8-week 563 
intervention. 564 
Week 
0        1    4        8          12 
Baseline 
Quality of life 
Anthropometrics 
Lung function 
PA assessment 
8-week home-based exercise intervention 
Up to 3 session per week 
Individually tailored intensity and duration 
Mid-intervention 
(week 4) 
PA assessment 
Intervention completion 
(week 8) 
Feedback questionnaire 
Quality of life 
Anthropometrics 
Lung function 
PA assessment 
Follow-up 
(12 weeks) 
PA assessment 
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SKYPE STUDY FEEDBACK QUESTIONNAIRE. 
Thank you for taking part in this Research Study at the RD&E. We would be grateful if you 
would complete this questionnaire about your experience as a Research participant so that 
we can improve the service we provide. 
 
The information you provide will be collected by the Research and Development team and 
will be treated in the strictest confidence. It will not affect any further treatment or 
participation in a Research Study. 
Thank you. 
 
About Skype. 
Did you use Skype or similar software before now? 
 
 
YES 
 
NO 
If YES please state which software you used: 
 
How easy/difficult was it to set up Skype?  
EASY 
 
OK 
 
DIFFICULT 
Which (if any) issues did you encounter? 
 
 
What device are you using for Skype?  
DESKTOP 
 
LAPTOP 
 
TABLET 
 
SMARTPHONE 
Have you had any connection issues?  
YES 
 
NO 
What internet connection are you using?  
3G 
 
4G 
 
BROADBAND 
 
FIBREBROADBAND 
 
WIFI 
How was the sound quality?  
GOOD 
 
OK 
 
BAD 
How was the video quality?  
GOOD 
 
OK 
 
BAD 
Did you find using Skype for an exercise session useful? 
 
Not at all    1 2 3 4 5 6 7 8 9 10   very useful 
How could this format of appointment be improved? 
 
 
Overall comments/opinions: 
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About the Study. YES PARTLY NO 
Was the study information sheet easy to understand?    
Did the Research Team answer questions about the study in a way 
that you could understand? 
   
Did you know what was expected of you when you agreed to take 
part in the study? 
   
Do you feel it is important to take part in Research?    
Would you be happy to take part in another Research Study?    
General Satisfaction. 
 
POOR FAIR GOOD 
VERY 
GOOD 
EXCELLENT 
My overall satisfaction with taking part in 
this Research Study is:- 
     
 
Please add any further comments about your experience of taking part in this study:- 
 
 
 
 
 
 
Please tell us your reasons for taking part in this study.  Circle all the options which apply. 
1) To help others 2) Own benefit 3) Felt obliged 4) Other – please specify: 
ADDITIONAL INFORMATION – PLEASE CIRCLE 
AGE 
GROUP 
11-16 17-21 22-30 31-40 41-50 51-60 61-70 71-80 80+ 
 
Thank you for your help. 
RESEARCH TRIAL INFORMATION TO BE COMPLETED BY STUDY TEAM 
Study Title:  R&D Number: 
 
 
 
 
 
